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Cone photoreceptor disorders form a clinical spectrum of diseases that include progressive cone dystrophy (CD) and complete and
incomplete achromatopsia (ACHM). The underlying disease mechanisms of autosomal recessive (ar)CD are largely unknown. Our
aim was to identify causative genes for these disorders by genome-wide homozygosity mapping. We investigated 75 ACHM, 97
arCD, and 20 early-onset arCD probands and excluded the involvement of known genes for ACHM and arCD. Subsequently, we per-
formed high-resolution SNP analysis and identiﬁed large homozygous regions spanning the PDE6C gene in one sibling pair with
early-onset arCD and one sibling pair with incomplete ACHM. The PDE6C gene encodes the cone a subunit of cyclic guanosine mono-
phosphate (cGMP) phosphodiesterase, which converts cGMP to 50-GMP, and thereby plays an essential role in cone phototransduction.
Sequence analysis of the coding region of PDE6C revealed homozygous missense mutations (p.R29W, p.Y323N) in both sibling pairs.
Sequence analysis of 104 probandswith arCD and 10 probandswith ACHM revealed compoundheterozygous PDE6Cmutations in three
complete ACHM patients from two families. One patient had a frameshift mutation and a splice defect; the other two had a splice defect
and a missense variant (p.M455V). Cross-sectional retinal imaging via optical coherence tomography revealed a more pronounced
absence of cone photoreceptors in patients with ACHM compared to patients with early-onset arCD. Our ﬁndings identify PDE6C as
a gene for cone photoreceptor disorders and show that arCD and ACHM constitute genetically and clinically overlapping phenotypes.Impairment or death of the cone photoreceptor cells is the
clinical hallmark of cone disorders, which have an esti-
mated prevalence of 1:30,000–1:40,000.1,2 Achromatopsia
(ACHM) (MIM *600827) is a stationary congenital auto-
somal recessive cone disorder characterized by low visual
acuity (0.10–0.20 decimal Snellen equivalent), photo-
phobia, nystagmus, and severe color vision defects. Patients
with the complete ACHM subtype have no cone function
on electroretinogram (ERG), whereas those with incom-
plete ACHM have residual cone function. Cone dystrophy
(CD) (MIM *600827) is a progressive cone disorder inwhich
patients may initially have normal cone function but
develop progressive visual acuity loss, increasing photo-
phobia, color vision disturbances, and diminished cone
responses on ERG, usually in the ﬁrst or second decade of
life. The visual acuity of these patients generally worsens
to legal blindness before the fourth decade of life.3
The genetic basis of these disorders has been partly eluci-
dated during the last decade. Three genes have been impli-
cated in ACHM: CNGA3 (MIM *600053), CNGB3 (MIM
*605080), and GNAT2 (MIM þ139340). Mutations in these240 The American Journal of Human Genetics 85, 240–247, August 1genesexplainamajorityofcasesof thisdisease,buta fraction
of cases still remain unsolved.4–7 Several genes have been
identiﬁed for the autosomal dominant3,8,9 and X-linked
formsofCD,10,11 but little is knownabout thegenetic causes
of themost prevalent autosomal recessive (arCD) form. Four
genes have been implicated in this form: ABCA4 (MIM
*601691),12 CACNA2D4 (MIM *608171),13 CNGB3 (MIM
*605080),14 and KCNV2 (MIM *607604),15,16 which
together explain only ~10% of all cases.
We aimed to identify disease genes for cone photore-
ceptor disorders and investigated patients with ACHM
and arCD. Patients were ascertained from various op-
hthalmic centers in the Netherlands, Belgium, the United
Kingdom, and Canada. This study was approved by the
local and national medical ethics committees and adhered
to the tenets of the Declaration of Helsinki. All participants
provided signed, informed consent for participation in the
study, retrieval of medical records, and use of blood and
DNA for research.
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and updated by additional examinations including optical
coherence tomography (OCT) and fundus photography.
Recent ERGs were performed according to the recommen-
dations of the International Society for Clinical Electro-
physiology of Vision.17 Patients could be stratiﬁed into
three clinical categories: ACHM (n ¼ 75 probands), arCD
(n ¼ 97 probands), and a group who had clear documenta-
tion of progressive cone dysfunction but already had
impaired visual acuity in early childhood (early-onset
arCD; n ¼ 20 probands). We tested for the presence of
known ABCA4 mutations in all probands (A.A.H.J.T.,
unpublished data) and for the presence of CNGB3 variants
in all probands via sequence analysis.5,7 When CNGB3
variants were absent, all ACHM patients were analyzed
for CNGA3 and GNAT2 variants via sequence analysis.5,7
Finally, most of the arCD patients were analyzed for
KCNV2 variants via sequence analysis (A.A.H.J.T., unpub-
lished data). These studies resulted in 116 probands—i.e.,
11 ACHM, 85 arCD, and 20 early-onset arCD—with
unknown etiology who formed the basis of the present
genetic analyses.
We performed high-resolution SNP analysis (Affymetrix
GeneChip Genome-Wide Human Array 5.0) on a subset of
76 patients from 64 families with autosomal recessive cone
dysfunction from whom DNA was available. In 8 of these
64 families, the parents were consanguineous. Genotyping
was performed with Genotype Console software (Affyme-
trix), and regions of homozygosity were calculated with
Partek Genomics Solution software. Large identity by
descent (IBD) regions (i.e., >5 Mb) were found in all
consanguineous families and in 34 of the nonconsangui-
neous probands. In these 34 nonconsanguineous patients,
we found a total of 57 IBD regions larger than 5 Mb, with
an average size of 9 Mb (range 5–31 Mb).
In a sibling pair from a consanguineous marriage (family
B) and in a sibling pair from a nonconsanguineous family
(family A), we identiﬁed large homozygous regions on
chromosome 10 (11 Mb and 26 Mb, respectively) (Fig-
ure 1A). The common 26 Mb homozygous region in the
sibs from family A was the largest homozygous region
(SNP boundaries SNP_A-2260521 and SNP_A-1892358);
the second, third, and fourth largest regions measured 8,
4.3, and 4.2 Mb. The overlapping 11 Mb homozygous
region in the affected sibs of family B was the second
largest homozygous region (SNP boundaries SNP_A-
2003359 and SNP_A-1804692). The largest region in this
family spanned 25 Mb; the third and fourth largest regions
measured 10 and 6 Mb. The overlapping homozygous
region in both families spanned the PDE6C gene but no
other obvious candidate genes (Figure 1A; see also Table
S1 available online). These regions were not found in other
patients.
PDE6C encodes the cone a subunit of cyclic guanosine
monophosphate (cGMP) phosphodiesterase, an enzyme
consisting of two a and two g subunits that is essential
in the cone phototransduction cascade. It converts the
second messenger cGMP to 50-GMP during light exposure.The AmerThis results in closure of the cGMP-gated ion channel in
the cone outer segment membrane, leading to hyperpolar-
ization of the cell.18
Because PDE6C appeared to be an excellent candidate
for cone photoreceptor disorders, we performed direct
sequencing of all 22 exons (Figure 1B). We detected homo-
zygous missense mutations in exon 1 in both sibling pairs
of family A (Figures 1B–1D). The ﬁrst proband (AII-1) and
his brother (AII-2) carried a homozygous missense muta-
tion (p.R29W) affecting a conserved residue just upstream
of the ﬁrst GAF (GAF-A) domain (acronym derived from
proteins in which these domains were initially identiﬁed)
(Figure 1B). The arginine residue at position 29 is fully
conserved in all depicted orthologs of the cone and rod
a subunits (PDE6C and PDE6A), except for in bovine and
canine PDE6C (Figure 1E). The second proband (BII-1)
and her brother (BII-2) carried the homozygous missense
mutation p.Y323N (Figures 1C and 1D). This mutation
affects a fully conserved residue located in the second
GAF (GAF-B) domain (Figures 1B and 1E, mutation M4),
a region of the protein that binds cGMP and regulates
the activity of the enzyme.19 Protein homology modeling
of the GAF-B domain on the basis of a recent GAF-A crystal
structure19 shows that the p.Y323N mutation is located
near the cGMP binding site. Although not directly inter-
acting with cGMP, Y323 neighbors D322, which is in direct
contact with bound cGMP, as shown in Figure 2. D322
tightly interacts with cGMP by means of two hydrogen
bonds, one originating from the peptide main chain and
one originating from the aspartic acid side chain. Mutation
of Y323 to N is likely to alter the local backbone conforma-
tion and mobility and is also likely to affect D322 and its
interaction with cGMP. Both the orientation and the
mobility of the amino acids equivalent to D322 in other
GAF domains have been suggested to be of crucial impor-
tance in determining afﬁnity and selectivity of these
domains for cGMP.19 We hypothesize that the p.Y323N
mutation will probably alter the afﬁnity of cGMP for the
regulatory GAF-B domain.
Subsequently, we analyzed the remaining patients (n ¼
114) for additional mutations in the PDE6C gene by direct
sequencing of the coding region. Compound heterozygous
mutations were detected in two additional probands.
Patient CII-1 was compound heterozygous for a frameshift
mutation (c.257_258 dupAG; p.L87GfsX57) in exon 1 and
a 5 bp deletion (c.2367þ1delGTAAG), which removes the
ﬁrst ﬁve nucleotides of intron 20, including the splice
donor site (Figures 1C and 1D). An alternative splice donor
site is predicted at position 2366 (splice prediction score
0.80, BGDP Splice Site Prediction by Neural Network).20
Use of this splice site would lead to a shift in the open
reading frame and premature termination of the phospho-
diesterase 6C protein (p.E790SfsX12). Patient DII-1 and her
affected sister (DII-2) revealed two missense variants
(c.633G/C [p.E211D] and c.1363A/G [p.M455V]) (Fig-
ure 1C). The glutamic acid at position 211 is changed to
the functionally conserved aspartic acid in ﬁve of sixican Journal of Human Genetics 85, 240–247, August 14, 2009 241
Figure 1. Molecular Genetic Characterization of the PDE6C Gene in Four Families with Autosomal Recessive Cone Photoreceptor
Disorders
(A) The 10q22-q25 region and the homozygous regions identiﬁed in patients of families A and B. The SNPs ﬂanking the homozygous
regions and their genomic positions, from the March 2006 UCSC genome build (hg18), are indicated.
(B) Protein and genomic structure of PDE6C. GAF, acronym derived from proteins in which these domains were initially identiﬁed
(cGMP-regulated mammalian phosphodiesterases, cyanobacterial adenylyl cyclases, and a formate-hydrogen lyase transcriptional acti-
vator); HDc, domain with highly conserved histidines (H) and aspartic acids (D); cc, coiled-coil domain. The six mutations are labeled
M1 through M6.242 The American Journal of Human Genetics 85, 240–247, August 14, 2009
homologous rod PDE b subunits, and in frog PDE6C,
strongly suggesting that the predicted amino acid change
is a functionally neutral variant. The c.633G/C variant
does, however, affect the last nucleotide of exon 2 and is
predicted to completely abolish the splice donor site
(BGDP Splice Site Prediction byNeural Network).20 Because
no alternative splice donor sites are predicted, themutation
may result either in removal of exon 2 from themRNAor in
nonsplicing of intron 2 (106 bp). In both options, this
would result in a disruption of the open reading frame.
The p.M455V mutation affects a conserved residue located
just downstream of the GAF-B domain (Figures 1B and 1E).
In those families in which DNAwas available from parents
(families B and D), mutations M3, M4, and M5 segregated
as expected for pathologic variants (Figure 1D). None of
the six PDE6C mutations were found in 180 ethnically
matched controls.
In four other unrelatedpatientswith arCD,we found four
different heterozygous amino acid changes (c.413T/C
[p.L138S], c.696G/A [p.M232I], c.2096A/G [p.E699G],
Figure 2. Molecular Modeling of Y323 in the GAF-B Domain of
PDE6C
The individual side-chain orientations of D322 and Y323 are
shown in magenta. A peptide backbone trace of the remainder
of the model is shown, with b sheets colored orange and a helices
colored blue. The mutation site Y323 is located adjacent to D322.
The latter amino acid is shown interacting with bound cGMP via
two hydrogen bonds, one originating from the peptide main
chain and one originating from the aspartic acid side chain.
Hydrogen bonds are indicated by yellow dashed lines.The Ameriand c.2477T/C [p.I826T]). In these patients, we did not
ﬁnd a second mutation on the other allele in the coding
region of this gene, despite complete PDE6C sequencing.
We considered the possibility of a digenic disease model,
with mutations in both PDE6C and an interacting gene,
and performed sequence analysis of the gene encoding
the cone g subunit of cGMP phosphodiesterase (PDE6H).
We did not detect mutations in this gene. The four hetero-
zygous variants in PDE6C were not detected in 180 ethni-
cally matched control individuals. The missense variants
p.M232I, p.E699A, and p.I826T were predicted by SIFT
software to be tolerated; only variant p.L138Swas predicted
not to be tolerated. Moreover, the isoleucine at position
826 is substituted by a threonine in the mouse and rat
orthologs, rendering this a very likely benign amino acid
change. The patients carrying the p.L138S, p.E699A, and
p.I826T variants were part of the 5.0 Affymetrix SNP
screening. A copy-number variant analysis of the SNP
data with Partek GS software did not reveal a deletion or
duplication of twenty intragenic SNPs and ﬁve copy-
number variant probes evenly spaced across the PDE6C
gene (Figure S1). Though very small deletions encompass-
ing single exonsorpart of thepromoter cannotbeexcluded,
these data strongly suggest that the heterozygous PDE6C
missense variants represent rare benign sequence variants.
Table 1 shows a summary of the clinical ﬁndings of all
patients with PDE6C mutations on both alleles. Patients
AII-1 and AII-2 carried a homozygous missense mutation,
located just upstream of the GAF-A domain (Figure 1A).
They showed an early-onset CD; their visual acuity and
cone ERG progressively declined in their early teens.
Patients BII-1 and BII-2 had a homozygous missense muta-
tion in the GAF-B domain, which presumably affects the
interaction with cGMP. This sibling pair presented with
an incomplete ACHM; the cone ERG responses were signif-
icantly reduced but measurable both in childhood and on
recent examination, whereas the rod ERG parameters were
normal. Patient CII-1, carrying a protein-truncating muta-
tion and a splice defect, had the most severe cone pheno-
type. At 4 years of age, the visual acuity was 0.10, the
cone ERG was nonrecordable, and the rod function was
completely normal (Figure 3). Patients DII-1 and DII-2,
each carrying a splice defect and a p.M455V missense(C) Chromatograms showing the PDE6C mutations.
(D) Pedigrees of early-onset cone dystrophy (family A), incomplete achromatopsia (family B), and complete achromatopsia (families C
and D) and segregation analysis of the respective PDE6C variants. The parents in family A are not related to each other in the last three
generations. BI-1 and BI-2 are ﬁrst cousins.
(E) Evolutionary conservation of the altered amino acid residues in three families. PDE6A and PDE6C are rod and cone a subunits respec-
tively; PDE6B is the rod b subunit. Using the Swiss-Prot database, we searched for their orthologs in as many species as possible and
included, with the exception ofDanio rerio, those present in all species.White lettered residues on a black background are fully conserved
between different species in all three subunits. White lettered residues on a gray background are conserved in most sequences. Black
lettered residues with light gray background are similar to amino acid residues in other orthologs and homologs. The arginine residue
at position 29 is fully conserved in all orthologs of both a subunits (PDE6C and PDE6A), except for bovine and canine PDE6C. The as-
partic acid residue in the GAF-A domain at position 211 is conserved or replaced by a functionally conserved glutamic acid residue in 19
of 20 orthologs and homologs. This observation strongly suggests that the predicted p.E211D substitution in family D is neutral and that
the effect of c.633G/C on the splice site is pathologic. The tyrosine residue located in the GAF-B domain at position 323 is completely
conserved among all three PDE6 subunits. The methionine residue at position 455 is conserved or substituted by a functionally
conserved isoleucine in all PDE6 molecules.can Journal of Human Genetics 85, 240–247, August 14, 2009 243
Table 1. Clinical F
















































































































































9indings in Probands and Affected Relatives, Stratified According to Genotype

















6 51 0.40 0.16 Yes Yes 11
Early-onset
CD
7 47 0.30 0.20 Yes Yes 3.5
Incomplete
ACHM
7 23 0.16 0.10 No Yes 10
Incomplete
ACHM
10 20 0.16 0.10 No Yes 2
57/ Complete
ACHM
2 4 0.10 0.10 Severe Yes þ10.5
/ Complete
ACHM
12 37 0.16 0.10 Severe Yes 5
/ Complete
ACHM
11 36 0.16 0.10 Severe Yes 1.5
ollows: BVCA, best corrected visual acuity; CD, cone dystrophy; ACHM, achromatopsia; ND, not determi
mutation, were clinically diagnosed as complete ACHM
because they exhibited a low visual acuity of 0.16 with
nystagmus since early childhood and absent cone re-
sponses on ERG.
In the adult patients, we performed Heidelberg Spectralis
OCT at the most recent ophthalmologic examination. The
absence of the photoreceptor cell layer in the fovea, a site
with predominantly cone photoreceptor cells, was
apparent in all patients. A typical OCT picture for patients
from family A (patient AII-2) is shown in Figure 4B; a char-
acteristic OCT image for patients from families B and D
(patient DII-1) is shown in Figure 4D. The area of absent
cone photoreceptors in patient DII-1, which spans almost
the entire fovea, is signiﬁcantly larger than the lesion in
patient AII-2 (Figures 4B and 4D). We hypothesize that
the missense variant in family A, which is located outside
functionally important domains, may have a less severe
effect on the function of PDE6C than the mutations
observed in the other families.
In zebraﬁsh, mutations in the ortholog of PDE6C are
responsible for progressive cone photoreceptor degenera-
tion.21,22 An intron 11 splice acceptor site mutation21
and a p.M175R missense mutation in the GAF-A domain22
lead to rapid degeneration of cone photoreceptors soon
after their formation. Unlike in humans, zebraﬁsh photo-
receptors are continuously generated at the retinal margin
by a population of mitotic progenitor cells, so cone photo-
receptors can be found at the periphery throughout the life
of these mutant ﬁsh. The splice site mutation in zebraﬁsh
also results in the degeneration of rod photoreceptors in
Figure 3. Electroretinogram of Patient
CII-1
An electroretinogram performed with an
abbreviated standard International Society
for Clinical Electrophysiology of Vision
protocol at the age of 4 years without seda-
tion is shown at top, with normal control
traces at bottom for purposes of compar-
ison. Note normal rod-speciﬁc response
(top trace at left),withnosigniﬁcantcontri-
bution of cones to combined rod-cone
response (bottom trace at left for patient
CII-1); dark-adapted oscillatory responses
as seen on ascending limb of the b-wave
are residual at most. The absence of cone-
speciﬁc function was demonstrated by the
absence of cone-speciﬁc response to 30 Hz
ﬂicker stimulation (at right).
the central part of the retina.21 In
zebraﬁsh with the p.M175R missense
mutation, rods show an abnormal
morphology and rhodopsin mislocal-
ization but otherwise function nor-
mally.22 These ﬁndings suggest that
the effect of the zebraﬁsh Pde6c
p.M175R mutation is more cone-
speciﬁc than that of the Pde6c splice
defect.
To test the involvement of rod photoreceptors in
human patients, we repeated the ERG on the two oldest
patients with PDE6C mutations (AII-1 and AII-2; 47
and 51 years old, respectively), and we did not ﬁnd
abnormal rod responses. Normal rod responses were
also observed in patients CII-1, DII-1, and DII-2. We
concluded that rod involvement does not appear to be
a major consequence of PDE6C mutations in humans,
although some dysfunction of rods may still occur later
in life.
In conclusion, through homozygosity mapping of
patients with cone photoreceptor disorders from noncon-
sanguineous and consanguineous families, we identiﬁed
another causative gene, PDE6C. PDE6C has a crucial role
in the cone phototransduction cascade. Similar to the
other disease genes in this cascade (CNGA3, CNGB, and
GNAT2),4–6 PDE6Cmutations result in a severe early-onset
cone disorder. We show that early-onset CD, incomplete
ACHM, and complete ACHM form a continuous spectrum
of a similar etiology. The observed variability in pheno-
typesmay be a result of differences in the functional effects
of PDE6C mutations. Our ﬁndings will improve diagnosis
and counseling of patients and their families and represent
another step toward solving the etiology of cone photore-
ceptor disorders.
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Figure 4. Retinal Phenotypes of Early-Onset Cone Dystrophy and Complete Achromatopsia in Families A and D
(A) Fundus photography of the right eye of patient AII-2, performed at age 51 years, showingmyopic changes in the peripapillary region.
In themacular region,mild pigmentary changes are present. The arrow denotes the position of the optical coherence tomography (OCT)
image in (B).
(B) The Heidelberg Spectralis OCTof this patient reveals a serous detachment of the photoreceptor layer in the central fovea. The retinal
pigment epithelium is intact, but the outer and inner segments of the photoreceptors are absent. The length of the lesion is ~500 mm.
The OCT cross-section is not fully perpendicular.
(C) Fundus photography of the left eye of patient DII-1, performed at age 37 years, showingmild pigmentary changes in themacula. The
arrow denotes the position of the OCT image in (D).
(D) The Heidelberg Spectralis OCT of this patient displays a large area of ~1300 mm with absent cone photoreceptors, which involves
almost the entire fovea.Acknowledgments
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